Influence of minimal residual disease by multiparametric flow cytometry at day 15 of induction in risk stratification of children with B-cell acute lymphoblastic leukemia treated at a referral hospital in southern Brazil
AUTOR(ES)
Silva, Klerize Anecely de Souza; Spagnol, Fabiane; Farias, Mariela Granero; Alegretti, Ana Paula; Michalowski, Mariana Bohns; Daudt, Liane Esteves
FONTE
Hematol., Transfus. Cell Ther.
DATA DE PUBLICAÇÃO
2020-10
RESUMO
ABSTRACT Background: The minimal residual disease (MRD) is the most important prognostic factor for acute lymphoblastic leukemia (ALL) in children. This study aimed to investigate the influence of detecting the MRD by the multiparametric flow cytometry (MFC) at day 15 (D15) of the induction on the analysis of the risk group classifications of the different childhood ALL treatment protocols used in a referral hospital in southern Brazil. Method: We retrospectively reviewed the medical records of patients with B-cell ALL, aged 1 to 18 years, treated at a hospital from January 2013 to April 2017. Main results: Seventy-five patients were analyzed. Regarding the MRD by the MFC at D15, the analyses showed statistical significance when the MRD was grouped into three categories, < 0.1%, 0.1–10%, and > 10%, with the following distribution: 30.7%, 52.0%, and 17.3%, respectively. There was a significant association between D15 MRD-MFC < 0.1% and the likelihood of dying or relapsing and between D15 MRD-MFC > 10% and the likelihood of dying or relapsing. The cumulative hazard ratio for the relapse of patients with D15 MRD-MFC < 0.1%, 0.1–10%, and > 10% was 19.2%, 59.8%, and 80.1%, respectively. Conclusion: Our analysis suggests D15 MRD-MFC < 0.1% as a cut-off point for patients with more favorable outcomes and that the MRD at D15 in risk classifications is particularly useful for the stratification of patients with a more favorable prognosis.
Documentos Relacionados
- The utility of multiparametric flow cytometry for the detection of minimal residual disease in acute lymphoblastic leukemia
- Proposal for the standardization of flow cytometry protocols to detect minimal residual disease in acute lymphoblastic leukemia
- Sensitive and Specific Measurement of Minimal Residual Disease in Acute Lymphoblastic Leukemia
- Comparison between qualitative and real-time polymerase chain reaction to evaluate minimal residual disease in children with acute lymphoblastic leukemia
- The study of minimal residual disease in acute lymphoblastic leukaemia